Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Manzotti

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Personalized Medicine|May 23, 2018
Announcing a new partnership to promote personalized medicineElisa Manzotti
Regenerative Medicine|July 17, 2010
Introducing the special focus issue: cellular reprogramming and iPS cellsChris Mason, Elisa Manzotti
Regenerative Medicine|May 12, 2010
Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010Chris Mason, Elisa Manzotti
Regenerative Medicine|December 19, 2009
Stem cell nations working together for a stem cell worldChris Mason, Elisa Manzotti
Regenerative Medicine|September 28, 2010
Defeating stem cell tourism. ForewordChris Mason, Elisa Manzotti
Regenerative Medicine|November 12, 2009
Regen: the industry responsible for cell-based therapiesChris Mason, Elisa Manzotti
Regenerative Medicine|March 10, 2010
The Translation Cycle: round and round in cycles is the only way forward for regenerative medicineChris Mason, Elisa Manzotti
Regenerative Medicine|December 25, 2008
New era dawns for US stem cell researchChris Mason, Elisa Manzotti
Regenerative Medicine|September 19, 2009
Bioaesthetics and regenerative medicineChris Mason, Elisa Manzotti
Regenerative Medicine|May 15, 2009
Induced pluripotent stem cells: an emerging technology platform and the Gartner hype cycleChris Mason, Elisa Manzotti
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Personalized Medicine|May 23, 2018
Announcing a new partnership to promote personalized medicineElisa Manzotti
Regenerative Medicine|July 17, 2010
Introducing the special focus issue: cellular reprogramming and iPS cellsChris Mason, Elisa Manzotti
Regenerative Medicine|May 12, 2010
Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010Chris Mason, Elisa Manzotti
Regenerative Medicine|December 19, 2009
Stem cell nations working together for a stem cell worldChris Mason, Elisa Manzotti
Regenerative Medicine|September 28, 2010
Defeating stem cell tourism. ForewordChris Mason, Elisa Manzotti
Regenerative Medicine|November 12, 2009
Regen: the industry responsible for cell-based therapiesChris Mason, Elisa Manzotti
Regenerative Medicine|March 10, 2010
The Translation Cycle: round and round in cycles is the only way forward for regenerative medicineChris Mason, Elisa Manzotti
Regenerative Medicine|December 25, 2008
New era dawns for US stem cell researchChris Mason, Elisa Manzotti
Regenerative Medicine|September 19, 2009
Bioaesthetics and regenerative medicineChris Mason, Elisa Manzotti
Regenerative Medicine|May 15, 2009
Induced pluripotent stem cells: an emerging technology platform and the Gartner hype cycleChris Mason, Elisa Manzotti
Pageof 2